SISIPUSH: Evaluation of Hemolysis and Iatrogenic Anemia Using the Push-pull Method to Obtain Blood from Pediatric Patients with Central Venous Catheters (SISIPUSH)

October 23, 2024 updated by: University Hospital, Ghent

Anemia is frequently observed during hospitalizations, both in adults and children. In addition to the fact that anemia can be caused by an acute or chronic condition, blood samples taken during the hospital stay contribute to additional blood loss (so-called iatrogenic anemia).

For children, the relative amount of blood taken at each blood collection is greater than in adults. It is therefore expected that in children, due to the lower circulating blood volume, the relative impact of repeated blood sampling is greater and interventions such as sparing the number of blood samples or blood volume can have a relevant impact on the onset of anemia, the need for iron supplements or blood transfusions and the general clinical recovery.

For children, only limited data are available on the development of iatrogenic anemia during hospital stay. In a study of children in an intensive care unit, a decrease in hemoglobin of 0.7 g/dl can already be seen with an average stay of 4.5 days (and an average number of blood samples of 2.9) (François et al. Ped Crit Car Med, 2022). The average blood volume lost to blood samples during the stay is 3.9 ml/kg, which already corresponds to 5% of the total blood volume. Interventions to decrease the frequency of blood sampling or to perform the same analyses on a smaller blood volume (e.g. adapted, smaller blood tubes for children) are therefore useful in preventing the development of anemia during a hospital stay, especially in children.

Alternative methods have been described to save on blood volume when performing blood sampling, especially if these are performed via central venous catheters (surgically or non-surgically placed). To obtain a suitable sample via such catheters, the usual technique is to obtain 5 to 10 ml of blood and discard the volume (so-called "waste blood") before the sample for laboratory analysis is obtained (typically only 1-2 ml). A recently published technique is the so-called push-pull method (described by McBride et al, J Infus Nurs 2018), in which blood sampling can be performed without waste blood.

The push-pull technique has been studied in children, but mainly in oncological and intensive care units. Paired analyses have verified that the technique provides a reliable sample for most blood analyses, including blood count, electrolytes, liver and kidney function parameters, CRP, but also coagulation factors and therapeutic drug monitoring. The occurrence of complications, of which the development of catheter-related bacteremia is of particular importance, is not described. A beneficial effect on anemia onset has not yet been described, usually due to low patient numbers per study (23-35 patients).

In SISIPUSH, we compare the push-pull technique with the standard-of-care in hospitalised children who undergo blood sampling via a central venous catheter for diagnostic reasons (in the context of routine care). By means of a 1:1 randomization, eligible patients who gave informed consent are assigned to one of the two methods for the remainder of the hospitalization. From the moment of randomization until discharge from the hospital, data will be collected from the medical file that are collected routinely (number of blood samples, hemoglobin values, number of blood transfusions, markers of hemolysis, age and gender, reason for hospitalization, type of catheter) and compared between the two groups. In parallel, nurses score the easy of use and satisfaction with the procedure at each blood sample.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ghent, Belgium, 9000
        • Recruiting
        • Ghent University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • hospitalized patient at the Specialist Pediatric Department of Ghent University Hospital
  • age 0-18 years
  • presence of a central venous catheter for diagnostic or therapeutic reasons of the type surgically placed (Hickman, port-a-cath) or non-surgically placed (vena jugularis interna, subclavia, femoralis,...)
  • patent catheter with possibility of infusion of fluids and collection of blood on at least one of the lumens
  • clinical and/or radiographic confirmation of correct central position of the catheter tip
  • at least one blood collection per week hospitalization expected or already planned

Exclusion Criteria:

  • presence of a bloodstream or catheter related infection before or at the time of randomization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Push-pull technique
push-pull technique as described by McBride et al, J Infus Nurs 2018
Active Comparator: Control
Standard of care blood sampling method with waste blood
Standard of care method to obtain blood with waste blood

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of hemoglobin
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
trend of hemoglobin (from the first blood draw after randomization to the last blood draw during the same hospitalization), which is defined as the sum of the negative differences of hemoglobin determinations (grams per deciliter) between two consecutive blood draws
from randomization to discharge from the hospital or removal of the central venous catheter

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hemolysis
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
analysis of hemolysis parameters on all blood samples (distribution of serum potassium and lactate dehydrogenase between the two study populations)
from randomization to discharge from the hospital or removal of the central venous catheter
Anemia onset
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
proportion of patients diagnosed with anemia (hemoglobin <7 g/dl) during hospitalization
from randomization to discharge from the hospital or removal of the central venous catheter
Need for erytrocyte transfusion
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
number of patients undergoing a packed red blood cell transfusion during hospitalization, expressed as proportion of patients compared to total number of patients, in number of transfusions per total number of blood samples and in number of transfusions per day of hospitalization since inclusion
from randomization to discharge from the hospital or removal of the central venous catheter
Hemolytic samples
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
proportion of blood samples reported by the clinical laboratory as hemolytic
from randomization to discharge from the hospital or removal of the central venous catheter
Failed blood samples
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
proportion of blood samples that were not analyzable and reason for this (hemolysis or other)
from randomization to discharge from the hospital or removal of the central venous catheter
Bacteremia onset
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
proportion of patients with bacteremia (positive blood culture) during the course of the study
from randomization to discharge from the hospital or removal of the central venous catheter
Catheter dysfunction
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
proportion of patients in whom the central venous catheter had to be removed early due to dysfunction or infection
from randomization to discharge from the hospital or removal of the central venous catheter
Operator ease of use
Time Frame: from randomization to discharge from the hospital or removal of the central venous catheter
assessment of satisfaction (0-5) and complexity (0-5) of the procedure by the healthcare personnel performing the blood sampling
from randomization to discharge from the hospital or removal of the central venous catheter

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2024

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

October 23, 2024

First Submitted That Met QC Criteria

October 23, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

October 24, 2024

Last Update Submitted That Met QC Criteria

October 23, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ONZ-2024-0215

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

peer-reviewed publication

IPD Sharing Time Frame

January 2026

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatrics

Clinical Trials on Push-pull technique

Subscribe